UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): December 15, 2010

KIWA BIO-TECH PRODUCTS GROUP CORPORATION
(Exact name of registrant as specified in its charter)

Delaware
 
000-33167
 
77-0632186
(State or other jurisdiction of
incorporation)
 
(Commission File Number)
 
(IRS Employer Identification
No.)
         
   
310 N. Indian Hill Blvd., #702
Claremont, California
   
   
(Address of principal
executive offices)
   
         
   
91711
   
   
(Zip code)
   
         
   
(626) 715-5855
   
   
(Registrant’s telephone
number, including area code)
   
         
   
None.
   
   
(Former name or former
address, if changed since last
report)
   

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions.

¨
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

Item 5.07.  Submission of Matters to a Vote of Security Holders

On December 15, 2010, Kiwa Bio-Tech Products Group Corporation, a Delaware corporation (the “Company”), held an annual meeting of its stockholders (the “Annual Meeting”). Present at the Annual Meeting, in person or by proxy, were holders of 249,035,854 shares of the Company’s common stock, or 62.26% of all shares eligible to vote on the subject proposals.

Proposal 1

Messrs. Wei Li, Lianjun Luo, Xucheng Hu, and Prof. Qi Wang were elected to the Company’s board of directors for the term of one year as follows:

Name
 
For
 
Against
 
Abstain
 
Broker Non-Votes
Wei Li
 
131,226,366
 
0
 
9,346,219
 
243,226,872
Lianjun Luo
 
131,226,366
 
0
 
9,346,219
 
243,226,872
Xucheng Hu
 
131,226,366
 
0
 
9,346,219
 
243,226,872
Qi Wang
 
131,226,366
 
0
 
9,346,219
 
243,226,872

Proposal 2

Crowe Horwath (HK) CPA Limited was ratified as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2010.  The voting totals were as follows:

For
 
Against
 
Abstain
 
Broker Non-Votes
248,893,986
 
141,868
 
0
 
134,763,603

Proposal 3

The proposal to amend our Certificate of Incorporation to increase the total number of authorized shares from 400,000,000 to 800,000,000 shares was not approved.  The voting totals were as follows:

For
 
Against
 
Abstain
 
Broker Non-Votes
81,123,708
 
162,765,050
 
5,147,095
 
134,763,604
 
 

 

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: December 20, 2010

/s/ Wei Li
 
Wei Li
Chairman of Board of Directors and Chief Executive Officer